PropertyValue
?:abstract
  • The trimeric spike (S) protein of SARS-CoV-2 is the primary focus of most vaccine design and development efforts. Due to intrinsic instability typical of class I fusion proteins, S tends to prematurely refold to the post-fusion conformation, compromising immunogenic properties and prefusion trimer yields. To support ongoing vaccine development efforts, we report the structure-based design of soluble S trimers with increased yields and stabilities, based on introduction of single point mutations and disulfide-bridges. We identify regions critical for stability: the heptad repeat region 1, the SD1 domain and position 614 in SD2. We combine a minimal selection of mostly interprotomeric mutations to create a stable S-closed variant with a 6.4-fold higher expression than the parental construct while no longer containing a heterologous trimerization domain. The cryo-EM structure reveals a correctly folded, predominantly closed pre-fusion conformation. Highly stable and well producing S protein and the increased understanding of S protein structure will support vaccine development and serological diagnostics.
?:creator
?:doi
?:doi
  • 10.1038/s41467-020-20321-x
?:journal
  • Nat_Commun
?:license
  • cc-by
?:pdf_json_files
  • document_parses/pdf_json/38f6d0380b46ca56aedb1e2fa4f6d07493f24979.json
?:pmc_json_files
  • document_parses/pmc_json/PMC7801441.xml.json
?:pmcid
?:pmid
?:pmid
  • 33431842.0
?:publication_isRelatedTo_Disease
?:sha_id
?:source
  • Medline; PMC
?:title
  • Stabilizing the closed SARS-CoV-2 spike trimer
?:type
?:year
  • 2021-01-11

Metadata

Anon_0  
expand all